SignalHF vs Withings Scan Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Implicity
VS
by Withings

AI Verdict

SignalHF is designed for clinical teams to predict heart failure hospitalizations in patients with cardiac implantable electronic devices, enabling proactive intervention. In contrast, the Withings Scan Monitor provides personal and remote patient monitoring through smart devices, focusing on AFib detection, heart rate, and general vital health metrics. While both leverage AI in cardiology and are FDA-cleared, they address distinct clinical needs and utilize different data sources.

Choose SignalHF if…

Choose SignalHF if your clinical practice manages a significant population of patients with cardiac implantable electronic devices (CIEDs) and you aim to proactively prevent heart failure hospitalizations. This FDA-cleared AI algorithm is ideal for care teams seeking early, manufacturer-agnostic predictive insights to enable timely interventions and personalize care plans for high-risk individuals.

View SignalHF →

Choose Withings Scan Monitor if…

Choose Withings Scan Monitor if you are an individual seeking comprehensive personal health monitoring or a clinician looking for an accessible remote patient monitoring solution for a broader patient base. This device-based system excels at providing user-friendly, multi-metric data collection, including FDA-cleared ECG for AFib detection, heart rate, and other vital health metrics, empowering both patients and providers with actionable insights for general cardiovascular health and early disease detection.

View Withings Scan Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature SignalHF Withings Scan Monitor
Pricing Contact for pricing Device purchase with optional subscription for enhanced features and clinical services.
Deployment SaaS Device-based (smart scale, smartwatch) with cloud synchronization and mobile application.
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Withings Scan Monitor

Withings Scan Monitor, with its device-based deployment, mobile application, and automatic data synchronization, offers a highly intuitive and consumer-friendly user experience. While SignalHF streamlines complex clinical data for care teams, Withings' design prioritizes ease of interaction for a broader audience, including patients and professionals utilizing remote patient monitoring.

Clinical Value

SignalHF

SignalHF provides an FDA-cleared AI algorithm that predicts heart failure hospitalizations within 30 days, enabling early intervention and personalized care for a critical clinical event. While Withings offers valuable AFib detection and vital sign monitoring, SignalHF's predictive capability for preventing major adverse outcomes represents a higher impact clinical value.

Pricing & Value

Withings Scan Monitor

Withings Scan Monitor offers transparent and publicly available pricing for its devices and optional subscription services, allowing potential users to clearly assess the cost and value proposition. SignalHF's 'contact for pricing' model makes it difficult to evaluate its value without direct engagement, placing Withings at an advantage for pricing transparency.

Enterprise Readiness

SignalHF

SignalHF is designed as a SaaS platform with a 'unified platform for centralizing cardiac implantable device data,' explicitly targeting healthcare enterprises for seamless integration into clinical workflows. While Withings is HIPAA and FDA compliant, its device-based deployment for individual use, even with RPM capabilities, is less inherently structured for large-scale enterprise-wide clinical system integration compared to SignalHF.

Innovation

SignalHF

SignalHF's FDA-cleared AI algorithm for predicting heart failure hospitalizations within 30 days, by analyzing manufacturer-agnostic CIED data, represents a significant innovation in proactive disease management. While Withings innovates by bringing advanced health metrics and multi-lead ECG to consumer devices, SignalHF's predictive AI for a complex clinical outcome pushes the boundaries of clinical decision support.

Support & Docs

Withings Scan Monitor

Withings offers extensive public online resources, including FAQs, user manuals, and a community forum, along with enhanced support through its Withings+ subscription. Implicity (SignalHF) provides dedicated support teams and customer success managers for its enterprise clients, but Withings' broad and easily accessible documentation and tiered support options offer a more comprehensive ecosystem for its diverse user base.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature SignalHF Withings Scan Monitor
Name SignalHF Withings Scan Monitor
Primary Purpose Predicts heart failure hospitalizations within 30 days by analyzing data from various cardiac implantable electronic devices, enabling early intervention and personalized care. Offers FDA-cleared ECG for AFib detection, heart rate, and other vital health metrics for both personal use and professional remote patient monitoring, integrated into smart scales and smartwatches.
Company Implicity Withings
Key Analytical Focus / Detection FDA-cleared AI algorithm for heart failure prediction; predicts heart failure hospitalizations within 30 days. 6-lead ECG for Atrial Fibrillation (AFib) detection (Body Scan), Single-lead ECG for Atrial Fibrillation (AFib) detection (ScanWatch), Heart rate measurement and irregular rhythm notifications.
Data Source / Device Compatibility Manufacturer-agnostic compatibility with various CIEDs (pacemakers, ICDs, CRTs); analyzes physiological data, demographics, lead measurements, episodes, and therapies. Integrated into smart scales and smartwatches (Body Scan, ScanWatch).
Categories Cardiology AI Cardiology AI, Wearables & Remote Monitoring (RPM)

Videos

Demos, reviews, and walkthroughs featuring SignalHF and Withings Scan Monitor.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

SignalHF by Implicity is an FDA-cleared AI algorithm specifically designed to predict heart failure hospitalizations within 30 days. In contrast, Withings Scan Monitor is an AI-powered tool integrated into smart scales and smartwatches, offering FDA-cleared ECG for Atrial Fibrillation (AFib) detection, heart rate, and other vital health metrics.
SignalHF analyzes physiological data, demographics, lead measurements, episodes, and therapies collected from various cardiac implantable electronic devices (CIEDs) such as pacemakers, ICDs, and CRTs. Withings Scan Monitor utilizes data from its device-based ecosystem, including 6-lead or single-lead ECGs, heart rate, blood oxygen saturation (SpO2), and other metrics from smart scales and smartwatches.
SignalHF generates automatic alerts for care teams based on risk scores, enabling early intervention and personalized care plans to potentially avert hospitalizations. Withings Scan Monitor provides AFib detection and irregular rhythm notifications, with data automatically synchronizing to a mobile application for personal use and professional remote patient monitoring.
SignalHF offers manufacturer-agnostic compatibility, analyzing data from various CIEDs including those from Biotronik, Boston Scientific, and Medtronic. Withings Scan Monitor operates within its own ecosystem of smart scales and smartwatches, with data synchronizing to the Withings app.
For SignalHF, pricing details are not specified, and interested parties need to contact Implicity for information. Withings Scan Monitor involves a device purchase, such as the Body Scan device, with an optional subscription for enhanced features and clinical services like Cardio Check-Up reviews.
SignalHF uses an FDA-cleared AI algorithm to predict heart failure hospitalizations by analyzing diverse patient data and identifying subtle patterns. Withings Scan Monitor incorporates AI-powered features for 6-lead ECG AFib detection, heart rate measurement, and other vital health metric analysis.

Backers

Who funded each tool's parent company.

SignalHF

AI Tool Finder
AI-powered search. Results may not be comprehensive.